| Clinical features and outcomes of immune checkpoint inhibitor–associated AKI: a multicenter study FB Cortazar, ZA Kibbelaar, IG Glezerman, A Abudayyeh, O Mamlouk, ... Journal of the American Society of Nephrology 31 (2), 435-446, 2020 | 302 | 2020 |
| Acute kidney injury in patients treated with immune checkpoint inhibitors S Gupta, SAP Short, ME Sise, JM Prosek, SM Madhavan, MJ Soler, ... Journal for immunotherapy of cancer 9 (10), 2021 | 140 | 2021 |
| A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant N Murakami, P Mulvaney, M Danesh, A Abudayyeh, A Diab, ... Kidney international 100 (1), 196-205, 2021 | 121 | 2021 |
| Informed consent for off-label use of prescription medications Z Mithani AMA Journal of Ethics 14 (7), 576-581, 2012 | 30 | 2012 |
| Remdesivir in patients with estimated GFR< 30 ml/min per 1.73 m2 or on renal replacement therapy C Estiverne, IA Strohbehn, Z Mithani, JS Hirsch, R Wanchoo, PG Goyal, ... Kidney international reports 6 (3), 835-838, 2021 | 28 | 2021 |
| Lifesaving care for patients with kidney failure during the war in Ukraine 2022 N Stepanova, M Kolesnyk, Z Mithani, B Alkofair, RL Shakour, A Petrova, ... Clinical journal of the American Society of Nephrology 17 (7), 1079-1081, 2022 | 19 | 2022 |
| Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKI S Gupta, C Garcia-Carro, JM Prosek, I Glezerman, SM Herrmann, ... Journal for immunotherapy of cancer 10 (9), 2022 | 15 | 2022 |
| Immune checkpoint inhibitors in kidney transplant patients: a multi-center study N Murakami, P Mulvaney, M Danesh, A Abudayyeh, A Diab, ... Kidney international 100 (1), 196, 2021 | 12 | 2021 |
| Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancer S Gupta, IA Strohbehn, Q Wang, PE Hanna, R Seethapathy, JM Prosek, ... Kidney international 102 (4), 930-935, 2022 | 9 | 2022 |
| De Novo Donor-Specific Antibody Formation in Tacrolimus-Based, Mycophenolate Versus Mammalian Target of Rapamycin Immunosuppressive Regimens. Z Mithani, J Gralla, O Adebiyi, P Klem, JE Cooper, AC Wiseman Experimental and Clinical Transplantation: Official Journal of the Middle …, 2017 | 4 | 2017 |
| Conflict Nephrology: War and Natural Disasters T Gopolan, CM Ornelas-Brauer, T Barbar, Z Mithani, J Silberzweig Kidney360 4 (3), 405-408, 2023 | 1 | 2023 |
| Disaster Preparedness for Climate-Driven Atlantic Hurricanes for Patients Diagnosed with ESKD: PUB124 RL Shakour, Z Mithani, Z Espinel, G Wong-Parodi, JM Shultz Journal of the American Society of Nephrology 34 (11S), 1083, 2023 | | 2023 |
| Preparing patients diagnosed with ESKD for climate-driven Atlantic hurricanes R Shakour, Z Mithani, Z Espinel, JM Shultz Annals of Epidemiology 85, 132, 2023 | | 2023 |
| Acute kidney injury in patients treated with immune checkpoint inhibitors (vol 9, e003467, 2021) S Gupta, SAP Short, ME Sise, JM Prosek, SM Madhavan, MJ Soler, ... JOURNAL FOR IMMUNOTHERAPY OF CANCER 11 (4), 2023 | | 2023 |
| Assessment of a laboratory-based SARS-COV-2 antibody test among hemodialysis patients: A quality improvement initiative DE Cohen, G Marlowe, G Contreras, MA Sosa, JM Mendoza, O Lenz, ... medRxiv, 2020.08. 03.20163642, 2020 | | 2020 |
| Donor Specific Antibody (DSA) Formation in Tacrolimus-Based, Mycophenolate vs mTOR Immunosuppression Regimens.: Abstract# B977 Z Mithani, O Adebiyi, J Gralla, P Klem, J Cooper, A Wiseman Transplantation 98, 543, 2014 | | 2014 |
